✦ LIBER ✦

41 HER2-expression in advanced ovarian cancer: A prognostic and predictive marker? An study of the AGO ovarian study group

✍ Scribed by H.J. Lück; F. Kommoss; E. Riener; N. Arnold; H.P. Adams; F. Hilpert; A. Du Bois; J. Pfisterer

Book ID: 118620217
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 323 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90075-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improving first-line therapy of advanced

Improving first-line therapy of advanced ovarian cancer – the AGO Ovarian Cancer Study Group perspective

✍ A. Du Bois; J. Pfisterer; W. Meier; U. Wagner; for the ago Ovarian Cancer Study 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

929 POSTER Pre-operative selection crite

929 POSTER Pre-operative selection criteria for operability in recurrent ovarian cancer. a study of the AGO organkommission ovar and the AGO ovarian cancer study group (AGO-OVAR)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Prognostic factors for complete debulkin

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

✍ Pauline Wimberger; Nils Lehmann; Rainer Kimmig; Alexander Burges; Werner Meier; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Co-expression of angiogenic markers and

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: A Gynecologic Oncology Group study

✍ Angeles Alvarez Secord; Kathleen M. Darcy; Alan Hutson; Paula S. Lee; Laura J. H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 603 KB

RETRACTED: The prognostic and predictive

RETRACTED: The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study

✍ Eva-Katrin Riener; Norbert Arnold; Friedrich Kommoss; Stefan Lauinger; Jacobus P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Distribution of HER-2 overexpression in

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma : From the Danish “MALOVA” Ovarian Cancer Study

✍ Estrid V. S. Høgdall; Lise Christensen; Susanne K. Kjaer; Jan Blaakaer; Johannes 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

## Abstract ## BACKGROUND The HER‐2 (Human Epidermal Growth factor receptor‐2, also known as c‐__erb__‐2/__neu__) protooncogene encodes a transmembrane receptor protein, __M__~r~ 185,000. Studies have shown that the HER‐2 oncogene is overexpressed in approximately 25–30% of ovarian carcinoma (OC)